v3.26.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Disclosure Of Share Based Payment Arrangements Explanatory [Line Items]  
Schedule of share-based compensation expenses

​

​

​

​

​

​

​

​

​

​

​

Year ended December 31, 

​

  ​ ​ ​

2023

  ​ ​ ​

2024

  ​ ​ ​

2025

​

​

(in thousands)

Cost of revenues

​

$

157

 

173

 

89

Research and development

​

​

9,414

 

9,819

 

6,461

General and administrative

​

​

1,108

 

891

 

621

Sales and marketing

​

​

1,453

 

1,435

 

927

Total compensation

​

$

12,132

 

12,318

 

8,098

Income tax benefit

​

$

2,545

 

2,605

 

1,738

Schedule of RSUs activity under the long-term incentive plan

​

​

​

​

​

​

​

​

  ​ ​ ​

Number of

  ​ ​ ​

Weighted

​

​

Underlying

​

Average Grant

​

​

Shares for RSUs

​

Date Fair Value

Balance at January 1, 2023

 

792,209

​

 

6.71

Granted

​

1,710,607

​

 

5.68

Vested

​

(1,974,496)

​

 

5.91

Forfeited

​

(2,355)

​

 

9.81

Balance at December 31, 2023

 

525,965

​

 

6.36

Granted

 

2,014,386

​

​

5.68

Vested

 

(2,261,433)

​

​

5.88

Forfeited

 

(5,307)

​

​

7.33

Balance at December 31, 2024

 

273,611

​

​

5.29

Granted

​

862,516

​

​

8.65

Vested

​

(1,063,725)

​

​

7.96

Forfeited

​

(3,588)

​

​

5.09

Balance at December 31, 2025

​

68,814

​

​

6.14

Schedule of allocation of compensation expenses and related tax effects from the RSUs granted to employees under the long-term incentive plan

​

​

​

​

​

​

​

​

​

​

​

Year ended December 31, 

​

  ​ ​ ​

2023

  ​ ​ ​

2024

  ​ ​ ​

2025

​

​

(in thousands)

Cost of revenues

​

$

153

 

167

 

86

Research and development

​

​

9,353

 

9,751

 

6,427

General and administrative

​

​

1,108

 

891

 

620

Sales and marketing

​

​

1,449

 

1,430

 

924

Total compensation

​

$

12,063

 

12,239

 

8,057

Income tax benefit

​

$

2,545

 

2,605

 

1,738

CM Visual Technology Corp  
Disclosure Of Share Based Payment Arrangements Explanatory [Line Items]  
Schedule of valuation assumptions

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2021 Plan

​

2023 Plan

​

​

​

Granted in

​

Granted in

​

Granted in

​

​

  ​ ​ ​

2021

  ​ ​ ​

2023

  ​ ​ ​

2024

​

Valuation assumptions:

​

​

​

​

​

​

​

Expected dividend yield

 

0

%  

0

%  

0

%

Expected volatility

 

43.82

%  

44.17

%  

39.76

%

Expected term (years)

 

3.125

 

3.125

​

3.125

​

Risk-free interest rate

 

0.223

%  

1.081

%  

1.150

%

Schedule of stock option activity

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

​

  ​ ​ ​

  ​ ​ ​

Weighted

​

 

​

 

Weighted

 

average

​

 

​

 

average

 

remaining

​

​

Number

 

exercise

 

contractual

​

​

of shares

 

price

  ​ ​ ​

term

Balance at January 1, 2023

 

2,291,000

​

$

0.36

 

2.5

Granted

 

288,000

​

​

0.33

 

  ​

Exercised

 

—

​

​

—

 

  ​

Effect of capital reduction

​

(1,289,500)

​

​

0.36

​

​

Forfeited

 

—

​

​

—

 

  ​

Balance at December 31, 2023

 

1,289,500

​

​

0.50

​

1.5

Granted

​

1,201,000

​

​

0.32

​

​

Exercised

​

—

​

​

—

​

​

Forfeited

​

(138,000)

​

​

0.47

​

​

Balance at December 31, 2024

​

2,352,500

​

​

0.41

​

1.8

Granted

​

20,000

​

​

0.34

​

​

Exercised

​

—

​

​

—

​

​

Forfeited

​

(55,000)

​

​

0.41

​

​

Balance at December 31, 2025

​

2,317,500

​

​

0.41

​

1.3

Exercisable at December 31, 2025

 

1,722,000

​

 

0.44

 

1.0

Liqxtal Technology Inc  
Disclosure Of Share Based Payment Arrangements Explanatory [Line Items]  
Schedule of valuation assumptions

​

​

​

​

​

​

  ​ ​ ​

2025 plan

​

Valuation assumptions:

​

​

​

Expected dividend yield

 

13.76

%

Expected volatility

 

44.08

%

Expected term (years)

 

3.05

​

Risk-free interest rate

 

1.1815

%

Schedule of stock option activity

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

​

  ​ ​ ​

Weighted

​

​

​

​

Weighted

​

average

​

​

​

​

average

​

remaining

​

​

Number

​

exercise

​

contractual

​

​

of shares

​

price

​

term

Balance at January 1, 2025

 

—

​

$

—

 

—

Granted

 

681,000

​

 

0.65

 

—

Exercised

 

—

​

 

—

 

—

Forfeited

 

—

​

 

—

 

—

Balance at December 31, 2025

 

681,000

​

 

0.65

 

3.92

Exercisable at December 31, 2025

 

—

​

 

—

 

—

​